|
|
|
Substance Name: Flavoxate [INN:BAN]
RN: 15301-69-6
UNII: 3E74Y80MEY
InChIKey: SPIUTQOUKAMGCX-UHFFFAOYSA-N
Note
- A drug that has been used in various urinary syndromes and as an antispasmodic. Its therapeutic usefulness and its mechanism of action are not clear. It may have local anesthetic activity and direct relaxing effects on smooth muscle as well as some activity as a muscarinic antagonist.
Molecular Formula
- C24-H25-N-O4
Molecular Weight
- 391.4645
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Physical Properties
Classification Codes
- Autonomic Agents
- Parasympatholytics
- Peripheral Nervous System Agents
- Urological Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Flavoxate
- Flavoxate [INN:BAN]
MeSH Heading
- Flavoxate
Synonyms
- 2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylat
- EINECS 239-337-5
- Flavossato
- Flavossato [DCIT]
- Flavoxate
- Flavoxato
- Flavoxato [INN-Spanish]
- Flavoxatum
- Flavoxatum [INN-Latin]
- UNII-3E74Y80MEY
Systematic Names
- 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester
- Flavoxate
Registry Numbers
CAS Registry Number
- 15301-69-6
FDA UNII
- 3E74Y80MEY
System Generated Number
- 0015301696
Structure Descriptors
InChI
InChI=1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3InChIKey
SPIUTQOUKAMGCX-UHFFFAOYSA-NSmiles
CC1=C(Oc2c(cccc2C1=O)Physical Properties
| Physical Property | Value | Units | Temp (deg C) | Source |
|---|---|---|---|---|
| pKa Dissociation Constant | 7.3 | (none) | EXP | |
| log P (octanol-water) | 4.950 | (none) | EST | |
| Water Solubility | 10 | mg/L | 37 | EXP |
| Atmospheric OH Rate Constant | 1.51E-10 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.